1329792-63-3
Chemical Structure
Atovaquone-d5
Synonym(s): Atavaquone-d5
- CAS No.: 1329792-63-3
- Formula:C22H14D5ClO3
- Molecular Weight:371.87
IUPAC Name: 2-((1r,4r)-4-(4-chlorophenyl)cyclohexyl-1,2,2,6,6-d5)-3-hydroxynaphthalene-1,4-dione
InChIKey: KUCQYCKVKVOKAY-SCUSTGHCSA-N
SMILES: O=C1C([C@@]2([2H])C([2H])([2H])C[C@H](C3=CC=C(C=C3)Cl)CC2([2H])[2H])=C(C(C4=CC=CC=C41)=O)O
Biological Activity: Atovaquone-d5 is the deuterium labeled Atovaquone. Atovaquone (Atavaquone) is a potent, selective and orally active inhibitor of the parasite’s mitochondrial cytochrome?bc1?complex. Atovaquone is against human and ?P. falciparum?cytochrome?bc1?activity with IC50 values of 460 nM and 2.0 nM, respectively. Atovaquone is an antimalarial agent and has the potential for the investigation of neumocystis pneumonia, toxoplasmosis, malaria, and babesia[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Atovaquone-d5 | Atovaquone-d5 is the deuterium labeled Atovaquone. Atovaquone (Atavaquone) is a potent, selective and orally active inhibitor of the parasite’s mitochondrial cytochrome?bc1?complex. Atovaquone is against human and ?P. falciparum?cytochrome?bc1?activity with IC50 values of 460 nM and 2.0 nM, respectively. Atovaquone is an antimalarial agent and has the potential for the investigation of neumocystis pneumonia, toxoplasmosis, malaria, and babesia. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Atovaquone (Standard) | ≥98% | Atovaquone (Standard) is the analytical standard of Atovaquone. This product is intended for research and analytical applications. Atovaquone (Atavaquone) is a potent, selective and orally active inhibitor of the parasite’s mitochondrial cytochrome bc1 complex. Atovaquone is against human and P. falciparum cytochrome bc1 activity with IC50 values of 460 nM and 2.0 nM, respectively. Atovaquone is an antimalarial agent and has the potential for the investigation of neumocystis pneumonia, toxoplasmosis, malaria, and babesia. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
cis-Atovaquone-d4 | cis-Atovaquone-d4 is deuterium labeled Atovaquone. Atovaquone (Atavaquone) is a potent, selective and orally active inhibitor of the parasite’s mitochondrial cytochrome bc1 complex. Atovaquone is against human and P. falciparum cytochrome bc1 activity with IC50 values of 460 nM and 2.0 nM, respectively. Atovaquone is an antimalarial agent and has the potential for the investigation of neumocystis pneumonia, toxoplasmosis, malaria, and babesia. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Atovaquone-d4 | 99.8% | Atovaquone-d4 is the deuterium labeled Atovaquone. Atovaquone is a medication used to treat or prevent for pneumocystis pneumonia, toxoplasmosis, malaria, and babesia. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Atovaquone | 99.75% | Atovaquone (Atavaquone) is a potent, selective and orally active inhibitor of the parasite’s mitochondrial cytochrome bc1 complex. Atovaquone is against human and P. falciparum cytochrome bc1 activity with IC50 values of 460 nM and 2.0 nM, respectively. Atovaquone is an antimalarial agent and has the potential for the investigation of neumocystis pneumonia, toxoplasmosis, malaria, and babesia. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
